EVOKE WEALTH, LLC
Q2 2021 13F-HR Holdings
Net value change ($000)
+426,589
(19.3%)
New positions
89
Sold out positions
114
Turnover %
1.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| RPAR | 97,373 | 19.3% |
| IVV | 44,990 | 30.7% |
| World Gold TR | 18,407 | 18.7% |
| VTI | 17,967 | 33.1% |
| GUNR | 17,191 | 27.9% |
| VTV | 14,383 | 55.0% |
| VEA | 13,504 | 53.2% |
| TSLA | 11,647 | 907.1% |
| TIP | 11,304 | 12.1% |
| VAC | 11,218 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| IAU | -5,934 | -100.0% |
| EWY | -4,844 | -100.0% |
| TBT | -2,910 | -13.4% |
| UBER | -2,326 | -57.4% |
| TDOC | -1,319 | -92.7% |
| BAX | -1,264 | -21.0% |
| LOW | -1,031 | -9.6% |
| CLNE | -1,031 | -26.1% |
| Inari Medical, Inc. | -944 | -12.8% |
| VARIAN MEDICAL SYSTEMS INC | -821 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|